Treatment of onychomycosis with a short-pulsed Nd:YAG Laser (1064nm)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00007709

Enrollment

Registered

2015-01-20

Start date

2013-12-23

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

B35.1

Interventions

Group 1: Short-pulsed Nd:YAG Laser-treatment 4 times all 4-6 weeks, once daily application of the AmorolfinCreme, Study control 12 months Group 2: once- daily application of amorolfinCreme, Study dura

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: onychomycosis of toenail; positive fungal culture; positive PCR; legal age, written agreement

Exclusion criteria

Exclusion criteria: oral or topical anti-fungal agents in the preceding 6 months, non compliance; pregnancy; women in childbearing age or lactation, use of a legal carer

Design outcomes

Primary

Measure	Time frame
primary outcome is the complete clinical cure of onychomycosis nail and the lack of fungal infection by using fungal culture and PCR and the onychomycosis severity index (OSI).	—

Secondary

Measure	Time frame
secondary outcome is the growth of normal cured toenail (in mm), side effects and patients satisfaction (questionnaire) Photo documentation and questionnaire before and 3 months after the last laser treatment	—

Countries

Germany

Contacts

Public ContactChristian Raulin

Laserklinik

info@raulin.de0721 4647800

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026